地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18995651644
传真:18372041646
邮箱:sales@amyjet.com

GenDEPOT是一家领先的生物技术公司,致力于开发最有价值的生物研究产品。产品涵盖了生物学研究领域的各项创新技术。GenDEPOT的战略重点放在帮助研究人员改进他们的研究成果,降低成本,节省时间来完成他们的研究目标。此外,他们将通过不断改进我们的产品和服务,以满足我们的所有客户的需要。GenDEPOT产品包括细胞培养、细胞因子、生物检测试剂盒、核酸纯化、蛋白分离与分析、免疫印迹与免疫沉淀。
GenDEPOT is a leading Biotech company focused to be the most valued global provider of Biological Research Products. With a focus on the best solutions that help scientists meet research objectives, we bring together leading innovative technologies in Bioresearch Community. We are strategically focused on helping researchers improve their research results, reduce the cost to accomplish their research and save the time to fulfill their research goal.
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://arbor.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="GenDEPOT"> GenDEPOT
invivoCrown IV0103替换BioXCell BE0075-1
invivoCrown IV0103替换BioXCell BE0075-1
invivoCrown IV0107替换BioXCell BE0273
<艾美捷科技代理Vectorbiolabs品牌全系列产品
Vector Biolabs是一家专注于提供高质量AAV(腺相关病毒)和腺病毒产品的生物科技公司,总部位于宾夕法尼亚州费城。Vector Biolabs公司提供包括定制病毒载体生产、载体设计、克隆、扩增、包装、纯化和滴度测定在内的服务,并且拥有一个包含超过90,000种针对人类、小鼠和大鼠基因组定制的AAV产品目录,服务于包括生物制药公司和研究机构在内的全球客户。此外,Vector Biolabs 为研究界提供与基因表达、基因编辑和基因沉默相关的服务。

▍Vectorbiolabs公司的产品与服务
● AAV定制生产:根据客户需求,定制生产AAV载体,以满足特定的研究或治疗需求。
● AAV控制产品:提供一系列用于AAV基因治疗的控制产品,确保实验的准确性和可靠性。
● 腺病毒建设与扩增:提供腺病毒的构建和扩增服务,支持客户的病毒载体研究。
● shRNA筛选/验证与产品目录:提供shRNA筛选和验证服务,以及相关的产品目录,帮助客户进行基因沉默研究。
使用AAV进行基因治疗的好处:
①低免疫反应:AAV载体引发免疫反应的可能性较低,适合敏感应用。
②稳定的基因递送:提供非整合基因递送,降低诱变风险。
③可扩展的生产:确保从小规模到大规模的研究和临床试验的可靠供应。
④广泛的治疗应用:多功能性使其成为靶向大脑、肝脏和视网膜等器官的理想选择。
| 特性 | AAV | 腺病毒 (Adenovirus) |
| 基因表达 | 长期、稳定表达 | 快速、瞬时表达 |
| 免疫原性 | 低 | 高 |
| 装载容量 | ~4.7 kb | ~8 kb - 38 kb (大得多) |
| 趋向性/靶向能力 | 高 - 可通过不同衣壳定制 | 广泛,可靶向多种组织 |
| 最佳应用场景 | 体内研究,长期表达 | 体外 & 体内研究,癌症 & 疫苗研究 |
▍Vectorbiolabs部分产品列表
| 品名 | 货号 | AAV Serotype | AAV ITR | Promoter | Reporter | Storage Buffer | Titer | Viral Backbone | Volume (µL) |
| AAV1-LacZ | 7001 | AAV1 | AAV2 | CMV (ubiquitous) | LacZ | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV1-GFP | 7002 | AAV1 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV2-LacZ | 7003 | AAV2 | AAV2 | CMV (ubiquitous) | LacZ | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV2-GFP | 7004 | AAV2 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV5-LacZ | 7005 | AAV5 | AAV2 | CMV (ubiquitous) | LacZ | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV5-GFP | 7006 | AAV5 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV9-GFP | 7007 | AAV9 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV6-GFP | 7008 | AAV6 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV1-Cre | 7010 | AAV1 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV2-Cre | 7011 | AAV2 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV5-Cre | 7012 | AAV5 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV6-Cre | 7013 | AAV6 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
invivoCrown IV0119替换BioXCell BE0004-1
invivoCrown IV0119替换BioXCell BE0004-1
invivoCrown IV0119替换BioXCell BE0004-1

Cellular Dynamics公司可以大规模从干细胞诱导分化生产人类细胞,用于基础研究,药物发现和再生医学应用。CDI提供了几种末分化的细胞种类作为目录产品:iCell心肌细胞,iCell神经元,iCell内皮细胞和iCell肝细胞。 CDI的MyCell®产品组合能够为客户提供的供体样品进行重编程,基因编辑和分化。该公司还有几种来源于多能干细胞的原型产品,包括iCell心脏祖细胞,iCell造血祖细胞,iCell星形胶质细胞和iCell骨骼成肌细胞等。
Fujifilm, once a Company whose core business was photographic film, has diversified and strengthened its portfolio based on developing or acquiring proprietary technologies as well as a deeply held corporate philosophy of enhancing the quality of human lives worldwide. One key area of focus for the Company is Healthcare, and Fujifilm acquired Cellular Dynamics International in May 2015, renamed it to FUJIFILM Cellular Dynamics, Inc.(FCDI) in 2018 to drive innovation in this business area. We see great potential in FCDI as a key component in our mission to be the global leader in regenerative medicine and drug discovery through cutting-edge science and technology.
To date FCDI has already achieved leadership in the induced pluripotent stem cell (iPSC) field as one of the only companies in the world to industrially manufacture human cells derived from iPSCs with high quality, purity, and reproducibility and in virtually unlimited quantities. Not only have we achieved this across multiple healthy and diseased donors for the research market but also, we have begun to manufacture human cells under cGMP conditions – a requirement as these human cellular products move from a tool used in drug discovery into a therapy used in regenerative medicine applications.
Cellular Dynamics公司的主要产品包括:
iCell Cardiomyocytes
iCell Cardiac Progenitor Cells
iCell Neurons
iCell Astrocytes
iCell DopaNeurons
iCell Hepatocytes 2.0
iCell Hepatoblasts
iCell Skeletal Myoblasts
iCell Endothelial Cells
iCell Hematopoietic Progenitor Cells
iCell Macrophages
" data-original="http://arbor.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Cellular Dynamics"> Cellular Dynamics
invivoCrown IV0117替换BioXCell BE0223
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18327026838
传真:18771149750
邮箱:sales@amyjet.com
0.2587